Vystar's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vystar's ROI in the first quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Vystar Corporation's return on investment (ROI) in its first quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-7	-7	-6	-6	-6
Return On Investment (TTM)	-	-	-	-	-
VYST's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	3.31 %	-5.89 %	-6.49 %
Net Income (TTM) in Millions	-1	-2	2	2	2

VYST Company Profile >> Back to VYST Roi Comparisons >> See Annual VYST Return On Investment

Return On Investment VYST's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Vystar's I. Quarter Investments	$ -7 Millions	VYST's Balance sheet
Vystar's I. Quarter Income	$ 0 Millions	Quarterly VYST's Income Statement
VYST's Income by Division		See VYST's Income by Division

VYST Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	-7	-5	-7	6	5
Y / Y Investment Growth	-	-	-	23.57 %	0.44 %
Net Income in Millions	-2	3	-8	-4	-2
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-71.27 %	-33.36 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VYST's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VYST's Competitors
Subscribers only: Roi for Vystar's Suppliers
Subscribers only: Return On Investment for VYST's Customers

Other Ratios
VYST's Roa	VYST's Inventory Turnover Ratio	VYST's Growth Rates	VYST's Dividend Statistics
	VYST's Profitability Ratios	VYST's Asset Turnover Ratio	VYST's Dividend Growth
VYST's Roe	VYST's Valuation Ratios	VYST's Financial Strength Ratios	VYST's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector	ROI
Oramed Pharmaceuticals Inc	54.33 %
Aurinia Pharmaceuticals Inc	54.02 %
Vaxart Inc	51.45 %
Escalon Medical Corp	51.07 %
Tg Therapeutics Inc	50.62 %
Zevra Therapeutics Inc	50.45 %
Idexx Laboratories Inc	50.05 %
Theravance Biopharma inc	43.85 %
Elite Pharmaceuticals Inc	43.22 %
Dariohealth Corp	40.59 %
Innoviva Inc	36.71 %
Indivior Pharmaceuticals Inc	36.55 %
Eli Lilly And Company	36.13 %
Abeona Therapeutics Inc	35.03 %
Lifemd Inc	34.80 %
Acadia Pharmaceuticals Inc	34.03 %
Mettler toledo International Inc	33.62 %
Adma Biologics Inc	30.38 %
Medpace Holdings Inc	30.34 %
Spero Therapeutics Inc	29.59 %
Rafael Holdings Inc	28.08 %
Incyte Corporation	27.50 %
Carlisle Companies Incorporated	24.39 %
Iradimed Corporation	23.59 %
Catalyst Pharmaceuticals Inc	23.58 %
Engene Therapeutics Inc	22.76 %
Protalix Biotherapeutics inc	22.70 %
Electromed Inc	22.36 %
Dexcom Inc	22.17 %
Illumina Inc	22.01 %

Date modified: 2026-09-26T07:06:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.